Assembly Summary | |
---|---|
Date Published | November 30, 2020 |
Length | 1,701,143 nt |
Sequencing Technology | Illumina + Oxford Nanopore Hybrid Assembly |
Number of Contigs | 3 (All Circularized) |
Assembly Level | Complete |
N50 | 1,618,466 nt |
%GC | 30.48% |
Organism Summary | |
---|---|
Name | ATCC® BAA-2151™ |
Isolation | Human patient during clinical trial. Isolated by the Center for Vaccine Development (CVD). |
Biosafety Level | 2 |
Type Strain | No |
Annotations Summary | |
---|---|
Number of CDS | 1,704 |
Number of Hypothetical Proteins | 203 |
Number of tRNA | 44 |
Number of 5s rRNA | 3 |
Number of 16s rRNA | 3 |
Number of 23s rRNA | 3 |
Input Reads Summary | |
---|---|
Oxford Nanopore Read Count | 248,437 |
Oxford Nanopore Median Q Score | 27 |
Illumina Read Count | 21,458,960 |
Illumina Mean Coverage Depth | 1,717.923× |
Illumina Median Q Score | 34 |
Contig | Start | End | Name | Protein Product | EC Number | Type | RefSeq ID | Jump |
---|
No genomes with >95% similarity found.
No genomes found sharing the same genus.